Menu
 
Research menu
Jump to menu

Publications:  Dr Craig Stiles

Stiles CE, Steeds RP, Drake WM(2020). Monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia. Ann Endocrinol (Paris)
10.1016/j.ando.2020.02.007
Stiles CE, Tetteh-Wayoe ET, Bestwick J, Steeds RP, Drake WM(2018). A meta-analysis of the prevalence of cardiac valvulopathy in hyperprolactinemic patients treated with Cabergoline. J Clin Endocrinol Metab
10.1210/jc.2018-01071
Stiles CE, Thuraisingham R, Bockenhauer D, Platts L, Kumar AV, Korbonits M(2018). De novo HNF1 homeobox B mutation as a cause for chronic, treatment-resistant hypomagnesaemia. Endocrinol Diabetes Metab Case Rep vol. 2018,
10.1530/EDM-17-0120
https://qmro.qmul.ac.uk/xmlui/handle/123456789/36267
Radian S, Diekmann Y, Gabrovska P, Holland B, Bradley L, Wallace H, Stals K, Bussell AM et al.(2017). Increased Population Risk of AIP-Related Acromegaly and Gigantism in Ireland. Human Mutation vol. 38, (1) 78-85.
10.1002/humu.23121
https://qmro.qmul.ac.uk/xmlui/handle/123456789/17888
Drake WM, Stiles CE, Bevan JS, Karavitaki N, Trainer PJ, Rees DA, Richardson TI, Baldeweg SE et al.(2016). A Follow-Up Study of the Prevalence of Valvular Heart Abnormalities in Hyperprolactinemic Patients Treated With Cabergoline. J Clin Endocrinol Metab vol. 101, (11) 4189-4194.
10.1210/jc.2016-2224
Rodd C, Millette M, Iacovazzo D, Stiles CE, Barry S, Evanson J, Albrecht S, Caswell R et al.(2016). Somatic GPR101 Duplication Causing X-Linked Acrogigantism (XLAG)—Diagnosis and Management. The Journal of Clinical Endocrinology & Metabolism vol. 101, (5) 1927-1930.
10.1210/jc.2015-4366
https://qmro.qmul.ac.uk/xmlui/handle/123456789/13770
Dénes J, Kasuki L, Trivellin G, Colli LM, Takiya CM, Stiles CE, Barry S, De Castro M et al.(2015). Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas. PLoS ONE vol. 10, (2)
10.1371/journal.pone.0117107
https://qmro.qmul.ac.uk/xmlui/handle/123456789/6951
Radian S, Gabrovska P, Holland B, Wallace H, Ryan AW, McGurren K, Stals K, Bussell A-M et al. (2014). Population Screening for the Irish Founder AIP Mutation R304*Reveals a Prevalence of 1/500 in the Local Population, While High Mutation Frequency Is Present Among Irish Familial and Sporadic Somatotropinoma Patients. ENDOCRINE REVIEWS. vol. 35,
Drake WM, Stiles CE, Howlett TA, Toogood AA, Bevan JS, Steeds RP, UK Dopamine Agonist Valvulopathy Group(2014). A cross-sectional study of the prevalence of cardiac valvular abnormalities in hyperprolactinemic patients treated with ergot-derived dopamine agonists. J Clin Endocrinol Metab vol. 99, (1) 90-96.
10.1210/jc.2013-2254
https://qmro.qmul.ac.uk/xmlui/handle/123456789/6756
Return to top